Martin Crook
Directeur/Membre du Conseil chez Cardior Pharmaceuticals GmbH
Profil
Martin Crook is currently a Director at Cardior Pharmaceuticals GmbH.
He obtained a doctorate degree from the University of Bristol in 2000, an undergraduate degree from the University of Lancaster in 1995, and a graduate degree from the University of Birmingham in 1996.
Postes actifs de Martin Crook
| Sociétés | Poste | Début |
|---|---|---|
Cardior Pharmaceuticals GmbH
 Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Directeur/Membre du Conseil | - |
Formation de Martin Crook
| University of Lancaster | Undergraduate Degree |
| University of Birmingham | Graduate Degree |
| University of Bristol | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Cardior Pharmaceuticals GmbH
Cardior Pharmaceuticals GmbH Pharmaceuticals: MajorHealth Technology Cardior Pharmaceuticals GmbH develops, manufactures and wholesales drugs. It focuses on the discovery, development and clinical validation of noncoding RNA therapeutics targeting microRNAs as medicines for patients with various forms of heart failure. The company was founded by Sandor Batkai, Claudia Ulbrich, and Thomas Thum on July 21, 2016 and is headquartered in Hannover, Germany. | Health Technology |